Cannabis and cancer are a pair that has been popping up in media reports over the last few years. Cannabis legalization is gaining more support and taking place in more places than ever before. Because of this, people are starting to develop a deeper understanding of this extremely misunderstood plant.
MedC Biopharma Working on Product for Skin Cancer
One company by the name of MedC Biopharma is working to establish a cannabis-based product to help treat a rare type of skin cancer called cutaneous T-cell lymphoma or CTCL for short. Medc Biopharma has done their research. They’re utilizing the molecules found in cannabis to encourage and create the Entourage Effect. A quote from the CEO of MedC Biopharma Guy Drori is below.
“Our product is based on production of specific particles in the plant, a combination of several of its molecules and a very precise dosage. Our formulation has no active ingredients that were not previously identified, but the selection of these ingredients and the precise ratios between them make this product unusual, as opposed to use of the complete cannabis plant or use of a single active ingredient, which makes it possible to register a patent on it and develop it as a drug.”
Raising Capital to Create Cures
MedC Biopharma founders have invested millions of dollars in addition to raising an estimated 5 million on top of their investments to support the venture. Cannabis as medicine is a big business. You can expect to see many mergers between companies and corporations over the next few years. At the head of the advisory board for MedC Biopharma sits Dr. Orna Meddriesen who is also chairperson and CEO of Nextar, a drug formulations company.
Nextar and MedC signed an arrangement that will see Nextar begin development for the formulations for other MedC Biopharma products. Cannabis legalization has opened many new doors, and many of these doors are leading to incredible health benefits. With cannabis legalization gaining more momentum, you can expect to see significant advancements. This is especially true in the field of cannabinoid medicine and research.